2016
DOI: 10.1007/978-3-319-27951-0_7
|View full text |Cite
|
Sign up to set email alerts
|

The Corn Smut Fungus Ustilago maydis as an Alternative Expression System for Biopharmaceuticals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
4
2

Relationship

4
2

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 112 publications
0
7
0
Order By: Relevance
“…As an alternative application, the screen will be employed to optimize our recently established protein expression platform ( Feldbrügge et al, 2013 ; Sarkari et al, 2016 ). Here, we use Cts1 as a carrier for valuable heterologous proteins.…”
Section: Discussionmentioning
confidence: 99%
“…As an alternative application, the screen will be employed to optimize our recently established protein expression platform ( Feldbrügge et al, 2013 ; Sarkari et al, 2016 ). Here, we use Cts1 as a carrier for valuable heterologous proteins.…”
Section: Discussionmentioning
confidence: 99%
“…The fact that ER/Golgi-mediated co- and post-translational modifications are avoided by unconventionally secreted proteins offers new possibilities for applications in biotechnology and medicine [ 20 , 21 ]. On this basis, we have established a novel system for protein production in the corn smut fungus Ustilago maydis .…”
Section: Introductionmentioning
confidence: 99%
“…Two such strains are available: the first carries a deletion of the preproprotease convertase Kexin 2 (Kex2) that activates secreted proteases, and in the second the genes for five major proteases were deleted sequentially. In these adapted strains other targets like single-chain variable fragments could also be secreted in an active state [ 21 , 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…Filamentous fungi harbor several homologs to glycosylationspecific genes studied from other organisms, possibly offering the opportunity to test posttranslationally modified proteins (Rosi-Marshall et al, 2007). Pathogens are often genetically tractable and promoters active at specific stages in the infection cycle are available, facilitating engineering of pathogens as Trojan horse delivery vehicles (Table 1); nowadays, some plant pathogens are even used as expression systems in biotechnology because of their exceptional protein folding and secretion capabilities (Royer et al, 1995;Sarkari et al, 2016). Therefore, we predict that the TH strategy of exploiting a pathogen to study secreted host proteins should be generalizable to a variety of host-pathogen interactions.…”
Section: Variety Of Monocots and Dicotsmentioning
confidence: 99%